Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs DISHMAN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES DISHMAN PHARMA ZYDUS LIFESCIENCES/
DISHMAN PHARMA
 
P/E (TTM) x 34.2 30.0 114.2% View Chart
P/BV x 5.8 3.3 172.5% View Chart
Dividend Yield % 0.6 0.7 89.8%  

Financials

 ZYDUS LIFESCIENCES   DISHMAN PHARMA
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-23
DISHMAN PHARMA
Mar-16
ZYDUS LIFESCIENCES/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs495374 132.2%   
Low Rs319129 247.8%   
Sales per share (Unadj.) Rs170.3197.0 86.4%  
Earnings per share (Unadj.) Rs19.821.2 93.3%  
Cash flow per share (Unadj.) Rs26.934.7 77.6%  
Dividends per share (Unadj.) Rs6.002.00 300.0%  
Avg Dividend yield %1.50.8 185.4%  
Book value per share (Unadj.) Rs173.0179.9 96.2%  
Shares outstanding (eoy) m1,012.2080.70 1,254.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.41.3 187.2%   
Avg P/E ratio x20.611.9 173.4%  
P/CF ratio (eoy) x15.17.3 208.6%  
Price / Book Value ratio x2.41.4 168.2%  
Dividend payout %30.39.4 321.4%   
Avg Mkt Cap Rs m412,14420,307 2,029.5%   
No. of employees `000NANA-   
Total wages/salary Rs m24,5645,355 458.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m172,37415,898 1,084.3%  
Other income Rs m4,746265 1,788.2%   
Total revenues Rs m177,12016,163 1,095.8%   
Gross profit Rs m29,6774,103 723.3%  
Depreciation Rs m7,2271,091 662.7%   
Interest Rs m1,299944 137.5%   
Profit before tax Rs m25,8972,334 1,109.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,878624 942.6%   
Profit after tax Rs m20,0191,710 1,170.7%  
Gross profit margin %17.225.8 66.7%  
Effective tax rate %22.726.7 84.9%   
Net profit margin %11.610.8 108.0%  
BALANCE SHEET DATA
Current assets Rs m100,08211,018 908.4%   
Current liabilities Rs m55,2679,517 580.7%   
Net working cap to sales %26.09.4 275.4%  
Current ratio x1.81.2 156.4%  
Inventory Days Days5057 88.2%  
Debtors Days Days943 2,674.1%  
Net fixed assets Rs m144,77618,787 770.6%   
Share capital Rs m1,012161 627.0%   
"Free" reserves Rs m174,14614,354 1,213.2%   
Net worth Rs m175,15814,516 1,206.7%   
Long term debt Rs m04,189 0.0%   
Total assets Rs m244,94029,805 821.8%  
Interest coverage x20.93.5 603.2%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.70.5 131.9%   
Return on assets %8.78.9 97.7%  
Return on equity %11.411.8 97.0%  
Return on capital %15.517.5 88.6%  
Exports to sales %39.224.9 157.5%   
Imports to sales %11.93.7 318.8%   
Exports (fob) Rs m67,5773,956 1,708.1%   
Imports (cif) Rs m20,544594 3,456.8%   
Fx inflow Rs m67,5774,952 1,364.8%   
Fx outflow Rs m20,544697 2,948.8%   
Net fx Rs m47,0334,255 1,105.4%   
CASH FLOW
From Operations Rs m26,8882,786 965.0%  
From Investments Rs m11,712-1,529 -766.0%  
From Financial Activity Rs m-44,004-941 4,676.3%  
Net Cashflow Rs m-5,338317 -1,686.6%  

Share Holding

Indian Promoters % 75.0 61.4 122.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 18.0 23.0 78.6%  
FIIs % 5.0 12.0 41.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 38.6 64.8%  
Shareholders   306,495 52,291 586.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on Cadila Healthcare vs Dishman Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cadila Healthcare vs Dishman Pharma Share Price Performance

Period Cadila Healthcare Dishman Pharma S&P BSE HEALTHCARE
1-Day 0.57% 2.87% 1.18%
1-Month 7.77% -2.45% -0.75%
1-Year 107.52% 96.38% 61.82%
3-Year CAGR 32.30% 89.34% 18.16%
5-Year CAGR 24.52% 38.20% 19.79%

* Compound Annual Growth Rate

Here are more details on the Cadila Healthcare share price and the Dishman Pharma share price.

Moving on to shareholding structures...

The promoters of Cadila Healthcare hold a 75.0% stake in the company. In case of Dishman Pharma the stake stands at 61.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cadila Healthcare and the shareholding pattern of Dishman Pharma.

Finally, a word on dividends...

In the most recent financial year, Cadila Healthcare paid a dividend of Rs 6.0 per share. This amounted to a Dividend Payout ratio of 30.3%.

Dishman Pharma paid Rs 2.0, and its dividend payout ratio stood at 9.4%.

You may visit here to review the dividend history of Cadila Healthcare, and the dividend history of Dishman Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.